Viramune, new antiretroviral agent, crosses the blood-brain barrier.
D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000493:pharmacokinetics / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D011725:Pyridines; D019829:Nevirapine